Johns Hopkins, Salk co-lead $15M bipolar disorder and schizophrenia initiative

Thursday, September 8, 2016

The Johns Hopkins University School of Medicine and the Salk Institute for Biological Studies will co-lead a $15.4 million effort to develop new systems for quickly screening libraries of drugs for potential effectiveness against schizophrenia and bipolar disorder, the National Institute of Mental Health (NIMH) has announced. The consortium, which includes four academic or nonprofit institutions and two industry partners, will be led by Hongjun Song, Ph.D., of Johns Hopkins and Rusty Gage, Ph.D., of Salk.

[Read More]

Sanford-Burnham, Pfizer partner in drug discovery

Thursday, November 3, 2011

Sanford-Burnham Medical Research Institute is the latest research organization to partner with Pfizer as part of Pfizer’s commitment to transforming research and development through a focus on translational medicine. The Centers for Therapeutic Innovation (CTI) is a research unit at Pfizer dedicated to open innovation through establishing global partnerships with academic research institutions to bridge the gap between discovery science and clinical applications.

[Read More]